U.S.Army Medical Research Institute of Chemical Defense (USAMRICD): Protect, Project, Sustain [open pdf - 3MB]
The mission of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) is to preserve combat effectiveness by timely provision of medical countermeasures in response to Joint Service Chemical Warfare Defense Requirements. This mission encompasses fundamental and applied research on the pharmacology, physiology, toxicology, pathology, and biochemistry of chemical warfare (CW) agents and their medical countermeasures. The Institute also researches, as part of its mission, pharmacological countermeasures for biological warfare (BW) agents. Through its research efforts, the Institute builds a science and technology base from which it transitions new pharmaceutical, materiel, and information products for the prevention, diagnosis, treatment, resuscitation, and medical management of casualties in a CW environment. The USAMRICD also provides scientific support for the advanced development and subsequent acquisition of the products of its research, and works with Army combat developers to formulate doctrine on their use. In addition to research, the Institute conducts a clinical training mission. The USAMRICD instructs Department of Defense (DOD) health care providers in the medical management of chemical casualties to save lives, minimize injury, maximize return to duty, and conserve fighting strength.